Celgene Corp (CELG) 119.23 $CELG
10 Reasons Why It's So Easy to Fall in Love With Celgene
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 26, 9:02AM CDT
Source: U.S. Food and Drug Administration. Today there are more than 300 biotech stocks listed on the major exchanges. They often come with a lot of risk -- most aren't profitable yet, and their valuations are predominantly based on the peak annual...
CELG: 119.23 (+6.53)
Celgene Corporation to Webcast Upcoming Investor Conferences in September
Business Wire - Wed Aug 26, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) plans to present at three upcoming investor conferences in September where Celgene management will provide an overview of the Company. The conferences will be webcast live and a link to the webcast will be available in the Investor Relations section of the Company's website at www.celgene.com.
CELG: 119.23 (+6.53), CELGZ: 1.68 (+0.12)
Celgene reports expiry of cash tender offer for Receptos' shares
M2 - Wed Aug 26, 4:09AM CDT
Biopharmaceutical company Celgene (NasdaqGS:CELG) disclosed on Tuesday the expiry of its tender offer to purchase any and all issued and outstanding shares of common stock of Receptos at a price of USD232.00 per share, net to the seller in cash, without interest and less required withholding taxes.
CELG: 119.23 (+6.53), CELGZ: 1.68 (+0.12)
Bouncing Biotech? 3 Stocks To Buy
Todd Campbell, The Motley Fool - Motley Fool - Tue Aug 25, 11:15AM CDT
Source: Flickr user stockmonkeys.com Although uncertainty may be the only market certainty, investors embracing long term investing have made money by buying big market drops time and time again. Given the market's nose-dive this month, that could...
GILD: 106.96 (+4.40), SNY: 49.13 (+1.30), REGN: 535.47 (+36.45), CELG: 119.23 (+6.53)
Why Acorda Therapeutics, Inc. Stock Surged Higher Today
George Budwell, The Motley Fool - Motley Fool - Tue Aug 25, 10:37AM CDT
What : Shares of Acorda Therapeutics , a biopharmaceutical company specializing in neurological disorders, saw its shares rise by as much as 21% today on exceptional volume, before settling in on a gain of 12% at the time of this writing. Acorda's...
ACOR: 31.96 (+0.59), CELG: 119.23 (+6.53)
Stocks Rocket At Starting Bell; Netflix, Apple, Facebook Jump
at Investor's Business Daily - Tue Aug 25, 9:37AM CDT
Stocks jumped out to broad gains early Tuesday, as a rate cut in China trumped a raft of below-forecast U.S. housing data. The Nasdaq grabbed the early lead with a 3% gain. The S&P 500 swung up 2.3% and the Dow Jones industrial average climbed 2%....
FB: 87.19 (+4.19), BBY: 35.25 (+2.30), ACOR: 31.96 (+0.59), ICLR: 78.95 (+3.28), CELG: 119.23 (+6.53), SBUX: 53.96 (+2.87), NFLX: 110.13 (+8.61), JPM: 62.91 (+3.00), BHP: 34.08 (+1.16), AAPL: 109.69 (+5.95), TOL: 35.98 (+0.90), UVE: 23.48 (-0.85)
Critical Alerts For Kinder Morgan, Celgene, Alibaba, American Airlines and SolarCity Released By InvestorsObserver
PR Newswire - Tue Aug 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for KMI, CELG, BABA, AAL and SCTY.
KMI: 30.79 (+0.86), SCTY: 43.05 (-0.58), AAL: 38.85 (+1.35), BABA: 68.66 (+0.09), CELG: 119.23 (+6.53)
An Inside Look at Biotech Investor Pros Dealing With Market Meltdown
at The Street - Tue Aug 25, 6:38AM CDT
Last night, I exchanged emails with a number of investors who run dedicated health care funds. I wanted to know how they navigated Monday's market selloff.
GILD: 106.96 (+4.40), IBB: 341.75 (+16.49), CELG: 119.23 (+6.53)
Celgene Announces Expiration of Cash Tender Offer for Shares of Receptos, Inc.
Business Wire - Tue Aug 25, 6:30AM CDT
Celgene Corporation (NASDAQ:CELG) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Receptos, Inc. at a price of $232.00 per share, net to the seller in cash, without interest and less required withholding taxes, expired at 12:00 midnight ET, at the end of the day on Monday, August 24, 2015.
RCPT: 231.99 (+0.04), CELG: 119.23 (+6.53), CELGZ: 1.68 (+0.12)
The Stock Market Isn't Worth Your Trust
at The Street - Tue Aug 25, 4:52AM CDT
But there are many companies who are.
GE: 24.01 (+0.74), CVS: 102.87 (+2.87), AAPL: 109.69 (+5.95), CELG: 119.23 (+6.53)
Markets Fall In China & Japan, U.S. Indices Could Follow – Markets This Morning
Dana Blankenhorn - Amigobulls - Tue Aug 25, 12:00AM CDT
A 7.6% fall in the Shanghai Composite and a 4% decline in the Nikkei signal more weakness for U.S. markets this morning. Oil prices will be of interest too.
AGN: 305.98 (+15.35), NFLX: 110.13 (+8.61), PXD: 108.86 (+1.62), FB: 87.19 (+4.19), EOG: 70.99 (+2.63), XOM: 72.50 (+3.79), AAPL: 109.69 (+5.95), REGN: 535.47 (+36.45), CELG: 119.23 (+6.53)
Look for Shares of Celgene to Potentially Rebound after Yesterday's 4.76% Sell Off
Comtex SmarTrend(R) - Mon Aug 24, 5:19PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.98 to a high of $120.20. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $118.92 on volume of 11.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 119.23 (+6.53)
Celgene Set to Possibly Rebound After Yesterday's Selloff of 4.76%
Comtex SmarTrend(R) - Mon Aug 24, 5:18PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.98 to a high of $120.20. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $118.92 on volume of 11.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 119.23 (+6.53)
Flash Crash-Like Selloff Met by Buyers; Cook’s Letter to Cramer Was ‘Significant’
at The Street - Mon Aug 24, 2:10PM CDT
The CNBC ‘Fast Money’ traders break down Monday’s violent selloff and subsequent rally. Apple CEO Tim Cook’s letter to Jim Cramer gave investors some clarity on China.
SBUX: 53.96 (+2.87), HD: 115.93 (+4.96), GILD: 106.96 (+4.40), PFE: 32.43 (+1.09), VZ: 45.16 (+1.66), AAPL: 109.69 (+5.95), CELG: 119.23 (+6.53)
Biotech Stocks Recover From Early-Morning Flash Crash
at The Street - Mon Aug 24, 11:43AM CDT
The iShares Nasdaq Biotechnology Index (IBB), the most closely followed biotech sector index, is down less than 1% after a deep plunge at Monday's open.
VRTX: 130.11 (+8.94), GILD: 106.96 (+4.40), XBI: 218.99 (+10.78), IBB: 341.75 (+16.49), CELG: 119.23 (+6.53)
Celgene (CELG) Breaks Through Support at $117.01
Comtex SmarTrend(R) - Mon Aug 24, 10:23AM CDT
Shares of Celgene (NASDAQ:CELG) opened today below their pivot of $120.96 and have already reached the first level of support at $117.01. Should the shares continue to fall, the support pivots of $114.97 and $108.98 will be of interest.
CELG: 119.23 (+6.53)
Stocks Down Hard, But Off Lows; All IBD 50 Stocks Lower
at Investor's Business Daily - Mon Aug 24, 9:28AM CDT
Stocks opened with substantial losses, but have done some repair work as global equity markets extend last week's sell-off. China's Shanghai composite plunged 8.5% and erased gains for the year. The Nasdaq trimmed an 8.8% deficit to 5% while the S&P...
PNK: 37.01 (+0.61), NKE: 108.76 (+5.23), PSA: 203.20 (+6.24), SCMP: 24.55 (+0.61), EBIX: 27.37 (+1.36), CELG: 119.23 (+6.53)
10 Reasons Why It's So Easy to Fall in Love With Celgene
Sean Williams, The Motley Fool - Motley Fool - Wed Aug 26, 9:02AM CDT
Source: U.S. Food and Drug Administration. Today there are more than 300 biotech stocks listed on the major exchanges. They often come with a lot of risk -- most aren't profitable yet, and their valuations are predominantly based on the peak annual...
CELG: 119.23 (+6.53)
Celgene Corporation to Webcast Upcoming Investor Conferences in September
Business Wire - Wed Aug 26, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) plans to present at three upcoming investor conferences in September where Celgene management will provide an overview of the Company. The conferences will be webcast live and a link to the webcast will be available in the Investor Relations section of the Company's website at www.celgene.com.
CELG: 119.23 (+6.53), CELGZ: 1.68 (+0.12)
Celgene reports expiry of cash tender offer for Receptos' shares
M2 - Wed Aug 26, 4:09AM CDT
Biopharmaceutical company Celgene (NasdaqGS:CELG) disclosed on Tuesday the expiry of its tender offer to purchase any and all issued and outstanding shares of common stock of Receptos at a price of USD232.00 per share, net to the seller in cash, without interest and less required withholding taxes.
CELG: 119.23 (+6.53), CELGZ: 1.68 (+0.12)
Bouncing Biotech? 3 Stocks To Buy
Todd Campbell, The Motley Fool - Motley Fool - Tue Aug 25, 11:15AM CDT
Source: Flickr user stockmonkeys.com Although uncertainty may be the only market certainty, investors embracing long term investing have made money by buying big market drops time and time again. Given the market's nose-dive this month, that could...
GILD: 106.96 (+4.40), SNY: 49.13 (+1.30), REGN: 535.47 (+36.45), CELG: 119.23 (+6.53)
Why Acorda Therapeutics, Inc. Stock Surged Higher Today
George Budwell, The Motley Fool - Motley Fool - Tue Aug 25, 10:37AM CDT
What : Shares of Acorda Therapeutics , a biopharmaceutical company specializing in neurological disorders, saw its shares rise by as much as 21% today on exceptional volume, before settling in on a gain of 12% at the time of this writing. Acorda's...
ACOR: 31.96 (+0.59), CELG: 119.23 (+6.53)
Stocks Rocket At Starting Bell; Netflix, Apple, Facebook Jump
at Investor's Business Daily - Tue Aug 25, 9:37AM CDT
Stocks jumped out to broad gains early Tuesday, as a rate cut in China trumped a raft of below-forecast U.S. housing data. The Nasdaq grabbed the early lead with a 3% gain. The S&P 500 swung up 2.3% and the Dow Jones industrial average climbed 2%....
FB: 87.19 (+4.19), BBY: 35.25 (+2.30), ACOR: 31.96 (+0.59), ICLR: 78.95 (+3.28), CELG: 119.23 (+6.53), SBUX: 53.96 (+2.87), NFLX: 110.13 (+8.61), JPM: 62.91 (+3.00), BHP: 34.08 (+1.16), AAPL: 109.69 (+5.95), TOL: 35.98 (+0.90), UVE: 23.48 (-0.85)
Critical Alerts For Kinder Morgan, Celgene, Alibaba, American Airlines and SolarCity Released By InvestorsObserver
PR Newswire - Tue Aug 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for KMI, CELG, BABA, AAL and SCTY.
KMI: 30.79 (+0.86), SCTY: 43.05 (-0.58), AAL: 38.85 (+1.35), BABA: 68.66 (+0.09), CELG: 119.23 (+6.53)
An Inside Look at Biotech Investor Pros Dealing With Market Meltdown
at The Street - Tue Aug 25, 6:38AM CDT
Last night, I exchanged emails with a number of investors who run dedicated health care funds. I wanted to know how they navigated Monday's market selloff.
GILD: 106.96 (+4.40), IBB: 341.75 (+16.49), CELG: 119.23 (+6.53)
Celgene Announces Expiration of Cash Tender Offer for Shares of Receptos, Inc.
Business Wire - Tue Aug 25, 6:30AM CDT
Celgene Corporation (NASDAQ:CELG) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Receptos, Inc. at a price of $232.00 per share, net to the seller in cash, without interest and less required withholding taxes, expired at 12:00 midnight ET, at the end of the day on Monday, August 24, 2015.
RCPT: 231.99 (+0.04), CELG: 119.23 (+6.53), CELGZ: 1.68 (+0.12)
The Stock Market Isn't Worth Your Trust
at The Street - Tue Aug 25, 4:52AM CDT
But there are many companies who are.
GE: 24.01 (+0.74), CVS: 102.87 (+2.87), AAPL: 109.69 (+5.95), CELG: 119.23 (+6.53)
Markets Fall In China & Japan, U.S. Indices Could Follow – Markets This Morning
Dana Blankenhorn - Amigobulls - Tue Aug 25, 12:00AM CDT
A 7.6% fall in the Shanghai Composite and a 4% decline in the Nikkei signal more weakness for U.S. markets this morning. Oil prices will be of interest too.
AGN: 305.98 (+15.35), NFLX: 110.13 (+8.61), PXD: 108.86 (+1.62), FB: 87.19 (+4.19), EOG: 70.99 (+2.63), XOM: 72.50 (+3.79), AAPL: 109.69 (+5.95), REGN: 535.47 (+36.45), CELG: 119.23 (+6.53)
Look for Shares of Celgene to Potentially Rebound after Yesterday's 4.76% Sell Off
Comtex SmarTrend(R) - Mon Aug 24, 5:19PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.98 to a high of $120.20. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $118.92 on volume of 11.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 119.23 (+6.53)
Celgene Set to Possibly Rebound After Yesterday's Selloff of 4.76%
Comtex SmarTrend(R) - Mon Aug 24, 5:18PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.98 to a high of $120.20. Yesterday, the shares fell 4.8%, which took the trading range below the 3-day low of $118.92 on volume of 11.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 119.23 (+6.53)
Flash Crash-Like Selloff Met by Buyers; Cook’s Letter to Cramer Was ‘Significant’
at The Street - Mon Aug 24, 2:10PM CDT
The CNBC ‘Fast Money’ traders break down Monday’s violent selloff and subsequent rally. Apple CEO Tim Cook’s letter to Jim Cramer gave investors some clarity on China.
SBUX: 53.96 (+2.87), HD: 115.93 (+4.96), GILD: 106.96 (+4.40), PFE: 32.43 (+1.09), VZ: 45.16 (+1.66), AAPL: 109.69 (+5.95), CELG: 119.23 (+6.53)
Biotech Stocks Recover From Early-Morning Flash Crash
at The Street - Mon Aug 24, 11:43AM CDT
The iShares Nasdaq Biotechnology Index (IBB), the most closely followed biotech sector index, is down less than 1% after a deep plunge at Monday's open.
VRTX: 130.11 (+8.94), GILD: 106.96 (+4.40), XBI: 218.99 (+10.78), IBB: 341.75 (+16.49), CELG: 119.23 (+6.53)
Celgene (CELG) Breaks Through Support at $117.01
Comtex SmarTrend(R) - Mon Aug 24, 10:23AM CDT
Shares of Celgene (NASDAQ:CELG) opened today below their pivot of $120.96 and have already reached the first level of support at $117.01. Should the shares continue to fall, the support pivots of $114.97 and $108.98 will be of interest.
CELG: 119.23 (+6.53)
Stocks Down Hard, But Off Lows; All IBD 50 Stocks Lower
at Investor's Business Daily - Mon Aug 24, 9:28AM CDT
Stocks opened with substantial losses, but have done some repair work as global equity markets extend last week's sell-off. China's Shanghai composite plunged 8.5% and erased gains for the year. The Nasdaq trimmed an 8.8% deficit to 5% while the S&P...
PNK: 37.01 (+0.61), NKE: 108.76 (+5.23), PSA: 203.20 (+6.24), SCMP: 24.55 (+0.61), EBIX: 27.37 (+1.36), CELG: 119.23 (+6.53)
